Navigation Links
Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco
Date:1/6/2009

MELVILLE, N.Y., Jan. 6 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), a leading provider of comprehensive home health services, announced today that it plans to present from 8:30 a.m. to 9:00 a.m. PT, Tuesday, January 13, 2009 at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco.

The presentation will be available to the public via a live audio web cast, which may be accessed by visiting http://investors.gentiva.com/events.cfm to register for the live event or listen to the archived version. Visitors to this site will also be able to request advance notifications of this or other upcoming Gentiva events.

Gentiva executives will give attendees an overview of the Company's operations and strategic priorities, and review opportunities for growth as the U.S. home health industry provides more services to an aging population.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is a leading provider of comprehensive home health services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-G

Forward-Looking Statement

Certain statements contained in this news rel
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Gentiva(R) Health Services Files Universal Shelf Registration Statement
2. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
3. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
4. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
5. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
6. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
7. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
8. Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
9. Gentiva(R) Health Services to Present March 3rd at Raymond James 29th Annual Institutional Investors Conference in Orlando
10. Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi
11. Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...sia/ -- Sundia MediTech, a leading,integrated pha...y in Shanghai,China announced today that Dr. Che...f Chemistry Services. , Prior to joining Su... drug,discovery and development company in San Di...Senior Director of Medicinal Chemistry of Neurocri...
(Date:7/3/2009)...com launches new content to include information ab...to best deal with these health issues. , ... -- ReverseAges.com has recently launched a new se...common health issues such as high blood pressure. ...ors, and the new content on ReverseAges.com addres...
(Date:7/3/2009)...h care reform details emerge, more entrepreneurs a...ps and business insurance premiums. Now, they are ...uch as the Small Business Health Insurance Network...neapolis, Minn. (PRWEB) July 3, 2009 -- The health...e, which has entrepreneurs worried about how this ...
(Date:7/2/2009)...re-USNewswire/ -- Acetaminophen is an ingredient f...icines to help relieve pain and reduce fever. Man...ylenol and prescription brand names, Vicodin and P... met on June 30, 2009 to address liver related inj...tee voted 20-17 to urge the FDA to put a ban on Vi...
Breaking Medicine News(10 mins):Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2
... about dropping salt-laden foods. The campaign gro...s begun working its way to beat// excess salt out ...ake a conscious decision to shun salty foods, whic...o reformulate such foods. The campaign has impress...
...remely common. Most people are down with at least ...rotective tips which could// help reduce the numbe...st cold and flu viruses are transmitted after cont...o much because of being sneezed over. In the cont...
...t that can travel inside your body, can find if yo...to a computer//. After being swallowed, the robot...nline edition of Daily Mail. The miniature video c...e can capture around 40,000 images of the intestin...
... anyone would willingly get into a mud bath. But t...nefit their health//, and these warm baths have a ...ght out the brownish-black mud in Bad Wilsnack in ...riginally to ease back pain or arthritis. Today, i...
Other Medicine News:Health News:Germany's Therapeutic Mud Baths Have Healing Qualities 2
(Date:6/30/2009)... , MIDLOTHIAN, Va., June 30 In ...s LC Plus nebulizer and PRONEB compressors (Ultra ...moterol fumarate (Perforomist, DEY LP, Mylan Inc.)...sed that researchers chose PARI products as the ex...ring maintenance treatments for COPD. Sutherland ...
(Date:6/30/2009)... , SAN DIEGO, June 30 Calixa Th...a Phase 2 clinical trial of CXA-101 in patients wi...is a new broad-spectrum, parenteral cephalosporin ... activity against Pseudomonas aeruginosa , includ...ing CXA-101 as a potential treatment for serious b...
(Date:6/29/2009)... , ROCHESTER, Minn., June 29 /PRNewswire-USNews...gate the effectiveness of deep brain stimulation...mpulsive disorder (OCD) and Tourette,s syndrome ar...world, according to a review in the June 2009 issu...stimulation has long been seen as valuable for con...
(Date:6/29/2009)... , SOUTHAMPTON, England, June 29 /PRNewswir...ical company developing novel, small molecule drug...nnounces positive results from,a Phase IIa clinic... for,nocturia. The trial showed that oral VA10648...ustained anti-diuretic effect in patients, as dete...
Breaking Medicine Technology:PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 1Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 2Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 3Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 4Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 5Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 6Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 7Cardium Announces InnerCools New RapidBlue 28TM 29 System Obtains CE Mark for Commercial Sale in Europe and UL certification 6528 889 percent of childrens food products provide poor nutritional quality 23899 189 percent of childrens food products provide poor nutritional quality 23899 289 percent of childrens food products provide poor nutritional quality 23899 389 percent of childrens food products provide poor nutritional quality 23899 4Sociological research shows combined impact of genetics social factors on delinquency 4005 1Sociological research shows combined impact of genetics social factors on delinquency 4005 2Aspire IRB Announces the Launch of an Automated Web Portal System 23895 1Aspire IRB Announces the Launch of an Automated Web Portal System 23895 2
...elgium, 2 July, 2007 -- Ablynx today announced pos...dy of its lead,development programme, ALX-0081, an...cute;first-in-class´ therapeutic,Nanobody&re...n,reduce the risk of thrombosis in patients with a...lthy volunteers is designed to assess,safety, tole...
...m cells cultivated from patients, own blood can,po... whose lower,extremities are affected by periphera..., SHENZHEN, China, July 02, 2007 /PRNewswire/ -- B...ref=,"http://www.beikebiotech.com/">http://www.bei... Dr. Yang Xiaofeng at its,collaborating hospital i...
Other Medicine Technology:Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 2Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 3
...ople are in need of MRI exams, many are diligently... They have heard of, or experienced first-hand, th...ubes of supercon scanners - "crypts" as some have ...ndly MRI. Now FONAR proudly introduces the FONAR 3...
Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance.
The Gemini XPS spectrofluorometer allows for fast, high-sensitivity measurements as required by most of today's fluorescence-based assays. Cellular and molecular binding studies, DNA quantitation, dr
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide
Medicine Products: